Article
Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.
Journal of molecular biology - 22 Jul 2011
Ozen Ayşegül, Haliloğlu Türkan, Schiffer Celia A
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the gag and gag-pro-pol polyproteins. HIV-1 PR inhibitors (PIs) are used in combination antiviral therapy but the emergence of drug resistance has limited their efficacy. The rapid evolution of HIV-1 necessitates consideration of drug resistance in novel drug design. Drug-resistant HIV-1 PR variants no longer...
Topics
Join the communities discussing this publication.
